Recent Quotes

My Watchlist

Indicators

Viking Thera (NQ: VKTX )

72.88 +0.34 (+0.47%)

Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	3,171,049
Open	73.67
Bid (Size)	73.20 (1)
Ask (Size)	73.48 (1)
Prev. Close	72.54
Today's Range	72.45 - 75.28
52wk Range	9.340 - 99.41
Shares Outstanding	99,581,693
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH

November 01, 2024

Madrigal sells an approved MASH treatment that blasted third-quarter sales views out of the water.

Via Investor's Business Daily

Viking Therapeutics Stock: A Pre-Election Bet Worth Considering

October 31, 2024

Viking Therapeutics is making headway in the weight loss drug market; but even though the payoff is years away, there's still plenty of upside for investors

Via MarketBeat

Performance

YTD	+298.69%	+298.69%
1 Month	+12.66%	+12.66%
3 Month	+37.38%	+37.38%
6 Month	-5.31%	-5.31%
1 Year	+645.19%	+645.19%

More News

This High-Flying Stock Just Became a Better Buy

October 31, 2024

Via The Motley Fool

Unpacking the Latest Options Trading Trends in Viking Therapeutics

October 29, 2024

Via Benzinga

Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today

October 28, 2024

Via Benzinga

Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?

October 27, 2024

Via The Motley Fool

3 Health Care Stocks Moving In Thursday's Intraday Session

October 24, 2024

Via Benzinga

An Overview of Viking Therapeutics's Earnings

October 22, 2024

Via Benzinga

Market Whales and Their Recent Bets on VKTX Options

October 22, 2024

Via Benzinga

S&P 500, Nasdaq Rise Sharply Ending 3-Day Losing Streak; Viking Therapeutics Surge, While Capri’s Shares Slump

October 25, 2024

Via Talk Markets

Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review

October 25, 2024

Via Investor's Business Daily

Why Viking Therapeutics Stock Soared by Nearly 21% on Thursday

October 24, 2024

Via The Motley Fool

Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years

October 10, 2024

Via Benzinga

UPS Posts Upbeat Q3 Results, Joins Tesla, Celestica, Pool, T-Mobile And Other Big Stocks Moving Higher On Thursday

October 24, 2024

Via Benzinga

How Viking Therapeutics Just Dealt A Blow To Eli Lilly's Obesity Triplet

October 24, 2024

Via Investor's Business Daily

3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia)

October 24, 2024

Via The Motley Fool

Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition

October 23, 2024

Via Benzinga

Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?

October 22, 2024

Via Benzinga

Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future

October 17, 2024

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session

October 16, 2024

Via Benzinga

Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade

October 14, 2024

Via Investor's Business Daily

Where Will Viking Therapeutics Be in 5 Years?

October 14, 2024

Via The Motley Fool

Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics

October 13, 2024

Via The Motley Fool

The Ultimate Biotech Stock to Buy With $100 Right Now

October 12, 2024

Via The Motley Fool

Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names

October 11, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.